Carbylan Therapeutics – Support Agreement (June 15th, 2016)
This SUPPORT AGREEMENT (this Agreement), dated as of June 15, 2016, is by and among KalVista Pharmaceuticals Ltd., a private company limited by shares incorporated and registered in England and Wales with number 07543947 and whose registered address is at Building 227 Tetricus Science Park, Porton Down, Salisbury, Wiltshire, SP4 0JQ (the Company), and the equityholders of Carbylan Therapeutics, Inc., a Delaware corporation (Carnivale), set forth on Schedule A hereto (each, an Equityholder and collectively, the Equityholders).
Settlement Agreement and Mutual Release (February 16th, 2010)
This Settlement Agreement and Mutual Release (Agreement) is entered into as of this 22ND day of October, 2009 (Effective Date) by and between BioForm Medical, Inc., a Delaware corporation (BioForm), and Advanced Cosmetic Intervention, Inc., a Colorado corporation. (ACI), (BioForm and ACI, as defined further herein, together, shall be referred to as the Parties and each a Party).
Third Amendment to the Bioform Medical 2007 Equity Incentive Plan (February 16th, 2010)
This Third Amendment (the Amendment) to the BioForm Medical, Inc. 2007 Equity Incentive Plan (the 2007 Plan), approved by the compensation committee of the board of directors of BioForm Medical, Inc. (the Company) on December 9, 2010 amends the 2007 Plan, effective as of December 9, 2010 as follows:
Bioform Medical, Inc. Directors Fee Plan (February 13th, 2009)
Asset Purchase Agreement (September 26th, 2008)
THIS ASSET PURCHASE AGREEMENT (this Agreement) is made as of April 29, 2008, by and between BioForm Medical, Inc., a Delaware corporation (Buyer or BioForm) and Advanced Cosmetic Intervention, Inc., a Colorado corporation (Seller or ACI). ACI and BioForm may be referred to herein individually as a Party and collectively as the Parties. Certain other capitalized terms used in this Agreement are defined in Section 1.